Could a

Childhood diarrhea Cost-benefit Economic model Growth faltering Shigella Vaccine stunting

Journal

Vaccine: X
ISSN: 2590-1362
Titre abrégé: Vaccine X
Pays: England
ID NLM: 101748769

Informations de publication

Date de publication:
Dec 2022
Historique:
received: 28 12 2021
revised: 03 06 2022
accepted: 19 09 2022
entrez: 14 10 2022
pubmed: 15 10 2022
medline: 15 10 2022
Statut: epublish

Résumé

Shigellosis is a leading cause of diarrhea and dysentery in young children from low to middle-income countries and adults experiencing traveler's diarrhea worldwide. In addition to acute illness, infection by

Identifiants

pubmed: 36237199
doi: 10.1016/j.jvacx.2022.100218
pii: S2590-1362(22)00078-X
pmc: PMC9551074
doi:

Types de publication

Journal Article

Langues

eng

Pagination

100218

Informations de copyright

© 2022 The Authors.

Déclaration de conflit d'intérêts

Dr. Kotloff receives funding from Institut Pasteur to conduct Shigella vaccine clinical trials. Dr. Lanata is a member of the World Health Organization (WHO) COVID-19 vaccine effectiveness working group and WHO Product Development Advisory Group. All other authors have no competing interests to declare.

Références

Pediatr Infect Dis J. 2001 May;20(5):525-30
pubmed: 11368112
EBioMedicine. 2017 Apr;18:109-117
pubmed: 28396264
Ann Hum Biol. 2019 Aug;46(5):415-424
pubmed: 31460800
Vaccine. 2016 Jun 3;34(26):2887-2894
pubmed: 26979135
BMJ Glob Health. 2017 Dec 28;2(4):e000370
pubmed: 29333282
Trop Med Int Health. 2018 Jan;23(1):26-33
pubmed: 29121442
Ann Epidemiol. 2013 Jun;23(6):314-20
pubmed: 23608305
J Nutr. 2010 Feb;140(2):348-54
pubmed: 20007336
Int J Med Microbiol. 2019 Mar;309(2):151-158
pubmed: 30733116
Am J Clin Nutr. 2016 Jul;104(1):104-12
pubmed: 27357091
Value Health. 2017 Apr;20(4):699-704
pubmed: 28408014
J Pediatr. 1994 Jul;125(1):14-22
pubmed: 8021764
Lancet. 2013 Aug 10;382(9891):525-34
pubmed: 23541370
N Engl J Med. 2020 Jul 23;383(4):321-333
pubmed: 32706533
Lancet Glob Health. 2019 Oct;7(10):e1398-e1413
pubmed: 31537370
J Pediatric Infect Dis Soc. 2021 Dec 31;10(12):1062-1070
pubmed: 34468743
Matern Child Nutr. 2017 Jan;13(1):
pubmed: 26607403
Am J Epidemiol. 2018 Oct 1;187(10):2210-2218
pubmed: 29767678
Lancet. 2008 Jan 19;371(9608):243-60
pubmed: 18207566
Lancet Glob Health. 2018 Dec;6(12):e1309-e1318
pubmed: 30287127
Vaccine. 2017 Dec 14;35(49 Pt A):6807-6812
pubmed: 28549806
PLoS One. 2020 Jan 24;15(1):e0227839
pubmed: 31978156
Am J Epidemiol. 1986 Apr;123(4):710-20
pubmed: 3953549
Pediatrics. 1984 Jun;73(6):799-805
pubmed: 6374599
Adv Nutr. 2019 Mar 1;10(2):196-204
pubmed: 30801614
Lancet Glob Health. 2019 Dec;7(12):e1664-e1674
pubmed: 31708147
Lancet. 2007 Jan 6;369(9555):60-70
pubmed: 17208643
PLoS Negl Trop Dis. 2020 Aug 17;14(8):e0008536
pubmed: 32804926
Gastroenterology. 2010 Oct;139(4):1156-64
pubmed: 20638937
Lancet. 2013 Jul 20;382(9888):209-22
pubmed: 23680352
Vaccine X. 2019 Apr 18;2:100024
pubmed: 31384741
Lancet. 2016 Sep 24;388(10051):1291-301
pubmed: 27673470
Vaccine. 1995 Nov;13(16):1488-94
pubmed: 8578831
Lancet Glob Health. 2019 May;7(5):e568-e584
pubmed: 31000128
Am J Clin Nutr. 2013 Dec;98(6):1555-63
pubmed: 24067665
Lancet. 2008 Jan 26;371(9609):340-57
pubmed: 18206223
BMC Med. 2019 Nov 25;17(1):214
pubmed: 31767012
Lancet Infect Dis. 2019 Jul;19(7):728-739
pubmed: 31130329
J Infect Dis. 1990 Mar;161(3):500-6
pubmed: 2313128
Vaccine X. 2019 Sep 20;3:100043
pubmed: 31687662
Pediatr Infect Dis J. 2014 Oct;33(10):1004-9
pubmed: 25361185
Nat Rev Gastroenterol Hepatol. 2013 Apr;10(4):220-9
pubmed: 23229327
Lancet Infect Dis. 2018 Nov;18(11):1229-1240
pubmed: 30266330
Public Health Nutr. 2005 Oct;8(7A):1191-201
pubmed: 16277829
Lancet Glob Health. 2018 Dec;6(12):e1319-e1328
pubmed: 30287125
J Infect Dis. 2021 Dec 20;224(12 Suppl 2):S848-S855
pubmed: 34528677
Proc Natl Acad Sci U S A. 2018 Sep 4;115(36):E8489-E8498
pubmed: 30126990
Clin Infect Dis. 2020 Jul 29;71(Suppl 2):S165-S171
pubmed: 32725237

Auteurs

Karoun H Bagamian (KH)

Bagamian Scientific Consulting, LLC, Gainesville, FL 32601, USA.
Department of Environmental and Global Health, University of Florida, Gainesville, FL 32603, USA.

Chloe Puett (C)

Stony Brook University, Department of Family, Population & Preventative Medicine, Program in Public Health, Stony Brook, NY 11794, USA.

John D Anderson (JD)

Bagamian Scientific Consulting, LLC, Gainesville, FL 32601, USA.

Farzana Muhib (F)

Center for Vaccine Innovation and Access, PATH, 455 Massachusetts Ave NW, Washington, DC 20001, USA.

Clint Pecenka (C)

Center for Vaccine Innovation and Access, PATH, Seattle, WA 98121, USA.

Jere Behrman (J)

Department of Economics and Sociology, University of Pennsylvania, Philadelphia, PA 19104, USA.

Robert F Breiman (RF)

Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA 30322, USA.

Ijeoma Edoka (I)

Health Economics and Epidemiology Research Office, Department of Internal Medicine, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

Susan Horton (S)

School of Public Health Sciences, University of Waterloo, Waterloo, ON N2L 3G1, Canada.

Gagandeep Kang (G)

Division of Gastrointestinal Sciences, Christian Medical College, Vellore 632004, India.

Karen L Kotloff (KL)

Department of Pediatrics, Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA.

Claudio F Lanata (CF)

Instituto de Investigacion Nutricional, Lima, Peru.

James A Platts-Mills (JA)

Division of Infectious Diseases & International Health, University of Virginia, Charlottesville, VA 22903, USA.

Firdausi Qadri (F)

International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh.

Elizabeth T Rogawski McQuade (ET)

Department of Epidemiology, Emory University, Atlanta, GA 30322, USA.

Christopher Sudfeld (C)

Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA.

Pascale Vonaesch (P)

Department of Fundamental Microbiology, University of Lausanne, Switzerland.

Thomas F Wierzba (TF)

Department of Internal Medicine, Section on Infectious Diseases, Winston-Salem, NC 27157, USA.

Suzanne Scheele (S)

Center for Vaccine Innovation and Access, PATH, 455 Massachusetts Ave NW, Washington, DC 20001, USA.

Classifications MeSH